In a move that has sent shockwaves through the Indian medical device industry, former U.S. President Donald Trump has imposed a 26% reciprocal tariff on medical device exports from India. This decision, aimed at correcting perceived trade imbalances and promoting domestic manufacturing in the U.S.,
The Association of Indian Medical Device Industry (AiMeD) today emphasized the need for the Indian government to revisit tariff structures considering the ongoing efforts to enhance healthcare security in India and address potential challenges arising from global health crises. In a statement, AiMeD expressed concern over
